All Stories

  1. Identification and validation of microRNAs that synergize with miR-34a – a basis for combinatorial microRNA therapeutics
  2. Enhancing MicroRNA Activity through Increased Endosomal Release Mediated by Nigericin
  3. Enhancing microRNA activity through increased endosomal release mediated by nigericin
  4. New Mechanism for Release of Endosomal Contents: Osmotic Lysis via Nigericin-Mediated K+/H+ Exchange
  5. MicroRNA-223 Suppresses the Canonical NF-κB Pathway in Basal Keratinocytes to Dampen Neutrophilic Inflammation
  6. No vehicle, no problem
  7. FolamiRs: Ligand-targeted, vehicle-free delivery of microRNAs for the treatment of cancer
  8. Targeting adhesion signaling in KRAS, LKB1 mutant lung adenocarcinoma
  9. Animal Models to Study MicroRNA Function
  10. Sulforhodamine B (SRB) Assay in Cell Culture to Investigate Cell Proliferation
  11. MicroRNAs in Cancer: A Historical Perspective on the Path from Discovery to Therapy
  12. RNA-guided CRISPR-Cas technologies for genome-scale investigation of disease processes
  13. Opportunities to integrate new approaches in genetic toxicology: An ILSI-HESI workshop report
  14. A combinatorial microRNA therapeutics approach to suppressing non-small cell lung cancer
  15. Aberrant Regulation and Function of MicroRNAs in Cancer
  16. Transcriptional Regulation of YWHAZ, the Gene Encoding 14-3-3ζ
  17. Small RNAs Deliver a Blow to Ovarian Cancer
  18. Integration of Apoptosis Signal-Regulating Kinase 1-Mediated Stress Signaling with the Akt/Protein Kinase B-I B Kinase Cascade
  19. Understanding the Epigenetic Interface Between the Cell and the Genome: A Supplemental Issue of DNA and Cell Biology on Epigenetics
  20. miRNA-34 Prevents Cancer Initiation and Progression in a Therapeutically Resistant K-ras and p53-Induced Mouse Model of Lung Adenocarcinoma
  21. Arresting the Culprit: Targeted Antagomir Delivery to Sequester Oncogenic miR-221 in HCC
  22. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy
  23. MicroRNA therapeutics in preclinical cancer models
  24. 14-3-3 zeta
  25. Inhibition of IκB Kinase-Nuclear Factor-κB Signaling Pathway by 3,5-Bis(2-flurobenzylidene)piperidin-4-one (EF24), a Novel Monoketone Analog of Curcumin
  26. Leucine toxicity in a neuronal cell model with inhibited branched chain amino acid catabolism
  27. Relationship of causative genetic mutations in maple syrup urine disease with their clinical expression
  28. Insulin increases branched-chain α-ketoacid dehydrogenase kinase expression in Clone 9 rat cells